These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15564506)

  • 1. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.
    Stadnick E; Dan M; Sadeghi A; Chantler JK
    J Virol; 2004 Dec; 78(24):13987-4002. PubMed ID: 15564506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
    Dunn JJ; Chapman NM; Tracy S; Romero JR
    J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
    Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
    J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.
    Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC
    Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
    Lee C; Maull E; Chapman N; Tracy S; Gauntt C
    J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.
    Dan M; Chantler JK
    J Virol; 2005 Jul; 79(14):9285-95. PubMed ID: 15994822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.
    Kiener TK; Jia Q; Meng T; Chow VT; Kwang J
    PLoS Negl Trop Dis; 2014; 8(5):e2895. PubMed ID: 24875055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
    Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
    J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of genomic RNA of Coxsackievirus B3 in murine myocarditis: reliability of direct sequencing of reverse transcription-nested polymerase chain reaction products.
    Zhang H; Soteriou B; Knowlson S; Theodoridou A; Archard LC
    J Virol Methods; 1997 Dec; 69(1-2):7-17. PubMed ID: 9504746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
    Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
    J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence.
    Cameron-Wilson CL; Pandolfino YA; Zhang HY; Pozzeto B; Archard LC
    Clin Diagn Virol; 1998 Apr; 9(2-3):99-105. PubMed ID: 9645991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the role of IRES stem-loop V in replicative capacities and translation efficiencies of Coxsackievirus B3 mutants.
    M'hadheb-Gharbi MB; Kean KM; Gharbi J
    Mol Biol Rep; 2009 Feb; 36(2):255-62. PubMed ID: 18027104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.
    Tu Z; Chapman NM; Hufnagel G; Tracy S; Romero JR; Barry WH; Zhao L; Currey K; Shapiro B
    J Virol; 1995 Aug; 69(8):4607-18. PubMed ID: 7609025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.
    Lee CK; Kono K; Haas E; Kim KS; Drescher KM; Chapman NM; Tracy S
    J Gen Virol; 2005 Jan; 86(Pt 1):197-210. PubMed ID: 15604447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs.
    Lee C; Maull E; Chapman N; Tracy S; Wood J; Gauntt C
    Virus Res; 1997 Aug; 50(2):225-35. PubMed ID: 9282787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva.
    Henke A; Nestler M; Strunze S; Saluz HP; Hortschansky P; Menzel B; Martin U; Zell R; Stelzner A; Munder T
    Virology; 2001 Oct; 289(1):15-22. PubMed ID: 11601913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
    Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
    Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis.
    Bailey JM; Tapprich WE
    J Virol; 2007 Jan; 81(2):650-68. PubMed ID: 17079314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
    Zaini Z; Phuektes P; McMinn P
    Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.